SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,856,000 | +72.4% | 49,660 | +40.7% | 0.01% | +71.4% |
Q1 2024 | $4,558,000 | +31.1% | 35,294 | -2.2% | 0.01% | +16.7% |
Q4 2023 | $3,476,000 | -10.0% | 36,071 | +12.9% | 0.01% | -14.3% |
Q3 2023 | $3,861,000 | +5.5% | 31,949 | -0.1% | 0.01% | 0.0% |
Q2 2023 | $3,658,000 | -29.4% | 31,980 | -14.8% | 0.01% | -36.4% |
Q1 2023 | $5,182,000 | +4.9% | 37,537 | -1.7% | 0.01% | 0.0% |
Q4 2022 | $4,940,000 | +16.2% | 38,169 | -0.7% | 0.01% | 0.0% |
Q3 2022 | $4,252,000 | +10.8% | 38,432 | -33.6% | 0.01% | +10.0% |
Q2 2022 | $3,837,000 | +25.6% | 57,865 | +48.4% | 0.01% | +42.9% |
Q1 2022 | $3,056,000 | -13.4% | 38,985 | -0.2% | 0.01% | -12.5% |
Q4 2021 | $3,529,000 | -5.4% | 39,063 | -3.4% | 0.01% | -20.0% |
Q3 2021 | $3,731,000 | +18.6% | 40,427 | +0.1% | 0.01% | +11.1% |
Q2 2021 | $3,147,000 | +25.0% | 40,386 | +19.5% | 0.01% | +12.5% |
Q1 2021 | $2,518,000 | -53.2% | 33,809 | +7.2% | 0.01% | -63.6% |
Q4 2020 | $5,382,000 | +35.5% | 31,539 | +10.8% | 0.02% | +15.8% |
Q3 2020 | $3,971,000 | -14.0% | 28,468 | -1.9% | 0.02% | -24.0% |
Q2 2020 | $4,616,000 | +56.9% | 29,030 | -4.3% | 0.02% | +31.6% |
Q1 2020 | $2,942,000 | -24.9% | 30,323 | -1.9% | 0.02% | -17.4% |
Q4 2019 | $3,920,000 | +61.8% | 30,906 | -6.6% | 0.02% | +76.9% |
Q3 2019 | $2,423,000 | -54.4% | 33,078 | -5.9% | 0.01% | -59.4% |
Q2 2019 | $5,319,000 | +9.8% | 35,134 | -13.9% | 0.03% | 0.0% |
Q1 2019 | $4,845,000 | +0.2% | 40,793 | -7.9% | 0.03% | -13.5% |
Q4 2018 | $4,833,000 | -38.3% | 44,314 | -8.7% | 0.04% | -33.9% |
Q3 2018 | $7,830,000 | +20.6% | 48,524 | -1.3% | 0.06% | +9.8% |
Q2 2018 | $6,491,000 | +48.6% | 49,176 | -16.6% | 0.05% | +37.8% |
Q1 2018 | $4,368,000 | +14.2% | 58,960 | -13.9% | 0.04% | +19.4% |
Q4 2017 | $3,824,000 | +20.7% | 68,518 | -1.8% | 0.03% | +14.8% |
Q3 2017 | $3,168,000 | +76.0% | 69,796 | +30.5% | 0.03% | +68.8% |
Q2 2017 | $1,800,000 | +30.2% | 53,477 | +13.6% | 0.02% | +23.1% |
Q1 2017 | $1,382,000 | +21.9% | 47,075 | +13.8% | 0.01% | +8.3% |
Q4 2016 | $1,134,000 | -40.0% | 41,350 | +34.2% | 0.01% | -45.5% |
Q3 2016 | $1,891,000 | +153.1% | 30,810 | -20.9% | 0.02% | +144.4% |
Q2 2016 | $747,000 | +116.5% | 38,957 | +120.7% | 0.01% | +800.0% |
Q1 2016 | $345,000 | – | 17,654 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |